Back to calendar
Spyre Therapeutics, Inc. (SYRE) Earnings
SYRE reports earnings on Tuesday, August 4, 2026
earnings report
August 4, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.72
Actual EPS: $-0.36
EPS surprise: 52.56%
Company overview
Market Cap$8.9B
PriceUSD 102.75
EPS (TTM)-2.36
52-week high108.14
52-week low14.51
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees102